MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rheumatology/keab943

Медицинская библиотека · Rheumatology (Oxford, England) · 2022

Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study.

Larosa Maddalena, Le Guern Véronique, Guettrot-Imbert Gaëlle, Morel Nathalie, Abisror Noémie, Morati-Hafsaoui Chafika, Orquevaux Pauline, Diot Elisabeth, Doria Andrea, Sarrot-Reynauld Françoise, Limal Nicolas, Queyrel Viviane, Souchaud-Debouverie Odile, Sailler Laurent, Le Besnerais Maëlle, Goulenok Tiphaine, Molto Anna, Pannier-Metzger Emmanuelle, Sentilhes Loic, Mouthon Luc, Lazaro Estibaliz, Costedoat-Chalumeau Nathalie, GR2 Group

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

The specific roles of remission status, lupus low disease activity state (LLDAS), and damage accrual on the prognosis of pregnancies in women with SLE are unknown. We analysed their impact on maternal flares and adverse pregnancy outcomes (APOs).

METHODS

We evaluated all women (≥18 years) with SLE enrolled in the prospective GR2 study with an ongoing singleton pregnancy at 12 weeks (one pregnancy/woman). Several sets of criteria were used to define remission, disease activity and damage. APOs included: foetal/neonatal death, placental insufficiency with preterm delivery and small-for-gestational-age birth weight. First trimester maternal and disease features were tested as predictors of maternal flares and APOs.

RESULTS

The study included 238 women (98.3% on hydroxychloroquine (HCQ)) with 230 live births. Thirty-five (14.7%) patients had at least one flare during the second/third trimester. At least one APOs occurred in 34 (14.3%) women. Hypocomplementemia in the first trimester was the only factor associated with maternal flares later in pregnancy (P=0.02), while several factors were associated with APOs. In the logistic regression models, damage by SLICC-Damage Index [odds ratio (OR) 1.8, 95% CI: 1.1, 2.9 for model 1 and OR 1.7, 95% CI: 1.1, 2.8 for model 2] and lupus anticoagulant (LA, OR 4.2, 95% CI: 1.8, 9.7 for model 1; OR 3.7, 95% CI: 1.6, 8.7 for model 2) were significantly associated with APOs.

CONCLUSION

LA and damage at conception were predictors of APOs, and hypocomplementemia in the first trimester was associated with maternal flares later in pregnancy in this cohort of pregnant patients mostly with well-controlled SLE treated with HCQ.

TRIAL REGISTRATION: ClinicalTrials.gov, https://clinicaltrials.gov, NCT02450396.

Для цитирования: Larosa Maddalena, Le Guern Véronique, Guettrot-Imbert Gaëlle, Morel Nathalie, Abisror Noémie, Morati-Hafsaoui Chafika, Orquevaux Pauline, Diot Elisabeth, Doria Andrea, Sarrot-Reynauld Françoise, Limal Nicolas, Queyrel Viviane, Souchaud-Debouverie Odile, Sailler Laurent, Le Besnerais Maëlle, Goulenok Tiphaine, Molto Anna, Pannier-Metzger Emmanuelle, Sentilhes Loic, Mouthon Luc, Lazaro Estibaliz, Costedoat-Chalumeau Nathalie, GR2 Group. Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study.. Rheumatology (Oxford, England). 2022. DOI: 10.1093/rheumatology/keab943.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.